July 2022

Barnette K et al, Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis, NEJM Evidence, Published July 6, 2022 DOI: https://doi.org/10.1056/EVIDoa2200145,
Full text

Choi D et al. Association of Blood Viscosity With Mortality Among Patients Hospitalized With COVID-19. J Am Coll Cardiol. 2022 Jul, 80 (4) 316–328. DOI:  https://doi.org/10.1016/j.jacc.2022.04.060
Full text

Fallach N et al, Pregnancy outcomes after SARS-CoV-2 infection by trimester: A large, population-based cohort study. PLOS. Published: July 20, 2022. DOI: https://doi.org/10.1371/journal.pone.0270893
Full text:

Goddard K et al, Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination, Vaccine, Published July 12,2022, DOI: https://doi.org/10.1016/j.vaccine.2022.07.007
Full text

Kim Y et al, Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection. JAMA. Published online July 22, 2022. doi:10.1001/jama.2022.12992
Full text

Lee K et al, Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination Science Advances, Published 15 Jul 2022 Vol 8, Issue 28 DOI: 10.1126/sciadv.abm7201
Full text

Nygaard U et al, Risk of Myopericarditis After COVID-19 Vaccination in Danish Children Aged 5 to 11 Years, Paediatrics, Published 26 July 2022, DOI: https://doi.org/10.1542/peds.2022-057508
Full text

Piernas C et al. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study. The Lancet Infectious Diseases, Published: June 30, 2022,  DOI: https://doi.org/10.1016/S2213-8587(22)00158-9
Full text

Pitre T et al, Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis CMAJ July 25, 2022 194 (28) E969-E980; DOI: https://doi.org/10.1503/cmaj.220471
Full text

Schneiderman M et al, Incidence and Relative Risk of COVID-19 in Adolescents and Youth Compared With Older Adults in 19 US States, Fall 2020. JAMA Netw Open. 2022;5(7):e2222126. doi:10.1001/jamanetworkopen.2022.22126
Full text

Tan S et al, Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age. NEJM Published July 20, 2022, DOI: 10.1056/NEJMoa2203209
Full text

Zilberman-Itskovich, S et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep 12, 11252 (2022). https://doi.org/10.1038/s41598-022-15565-0
Full text 

June 2022

Al-Aly, Z., Bowe, B. & Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med , 25 May 2022 DOI: https://doi.org/10.1038/s41591-022-01840-0
Full text
 
Antonelli A, et al.  Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. The Lancet, Published: June 18, 2022, DOI:https://doi.org/10.1016/S0140-6736(22)00941-2
Full text
 
Au WY, Cheung P P-H. Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2022-069989 (Published 31 May 2022)
Full text
 
Brownscombe JJ. et al. COVID‐19 highlights the need for action on pulse oximeter accuracy in people with dark skin. Med J Aust 2022; 216 (10): 539-539. || doi: 10.5694/mja2.51522 , Published online: 6 June 2022.
Full text
 
Cao, Y., Yisimayi, A., Jian, F. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature (2022). https://doi.org/10.1038/s41586-022-04980-y
Abstract
 
Dickerman BA, et al.  Comparative Safety of BNT162b2 and mRNA-1273 Vaccines in a Nationwide Cohort of US Veterans. AMA Intern Med. Published online June 13, 2022. doi:10.1001/jamainternmed.2022.2109
Full text
 
Harper T, Attwell K. How Vaccination Rumours Spread Online: Tracing the Dissemination of Information Regarding Adverse Events of COVID-19 Vaccines. Int J Public Health, 30 May 2022 DOI: https://doi.org/10.3389/ijph.2022.1604228
Full text
 
Higdon M, et al. Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant. The Lancet Infectious Diseases, Published: June 22, 2022, DOI:https://doi.org/10.1016/S1473-3099(22)00409-1
Full text
 
Liu, X. et al.  Safety and superior immunogenicity of heterologous boosting with an1
RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults. medRxiv preprint, DOI https://doi.org/10.1101/2022.05.30.22275753, May 31, 2022.
Full text
 
Najjar-Debbiny R. et al. Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients. Clinical Infectious Diseases, ciac443, DOI: https://doi.org/10.1093/cid/ciac443 Published: 02 June 2022.
Full text
 
Patel M, et al. Increasing children's global access to COVID-19 vaccines. The Lancet Volume 399, ISSUE 10342, P2171-2173, June 11, 2022. DOI: https://doi.org/10.1016/S0140-6736(22)00884-4
Full text
  
Reynolds CJ, et al. Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure. Science, 14 Jun 2022, DOI: 10.1126/science.abq1841
Full text
 
Rowntree LC, et al. SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection. Immunity, 2022; DOI: 10.1016/j.immuni.2022.06.003
Full text
 
Straus W, et al. Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide. Clinical Infectious Diseases, ciac446, https://doi.org/10.1093/cid/ciac446
Published: 06 June 2022.
Full text
 
Sylvester SV, et al. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. CMR, Published online: 20 Jun 2022. DOI: https://doi.org/10.1080/03007995.2022.2081454.
Full text
 
Vadrevu KM, et al. Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study. The Lancet Infectious Diseases, PublishedJune 16, 2022, DOI:https://doi.org/10.1016/S1473-3099(22)00307-3.
Full text
 
Watson, OJ. et al.  Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.The Lancet: Infectious Diseases, Published:June 23, 2022 DOI:https://doi.org/10.1016/S1473-3099(22)00320-6
Full text
 
Wu M, et al.  Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees. Science Advances 3 Jun 2022, Vol 8, Issue 22, DOI: 10.1126/sciadv.abn6064
Full text
 
Yang H. et al. The effect of strict lockdown on Omicron SARS-CoV-2 variant transmission in Shanghai. medRxiv Posted June 07, 2022. doi: https://doi.org/10.1101/2022.05.22.22275423
Full text
 
Yao, L et al. Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection. The Lancet Infectious Diseases, Published: June 20, 2022, DOI:https://doi.org/10.1016/S1473-3099(22)00410-8
Full text
 
Ye X, et al.  Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease, Cardiovascular Research, 22 June 2022, cvac068, https://doi.org/10.1093/cvr/cvac068
Full text

May 2022

Arbel, R., Sergienko, R., Friger, M. et al. Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years. Nat Med (2022). https://doi.org/10.1038/s41591-022-01832-0
Full text
 
Ayoubkhani, D. et al.  Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2021-069676 (Published 18 May 2022)
Full text
 
Cai, J., Deng, X., Yang, J. et al. Modeling transmission of SARS-CoV-2 Omicron in China. Nat Med (2022). https://doi.org/10.1038/s41591-022-01855-7
Full text
 
Callaway, E. Flu vaccine could cut COVID risk. Nature 605, 602 (2022), 16 May 2022,
doi: https://doi.org/10.1038/d41586-022-01315-9
Full text
 
Cameron A. Smith, Christian A. Yates, Ben Ashby. Critical weaknesses in shielding strategies for COVID-19. PLOS Global Public Health, 2022; 2 (4): e0000298 DOI: 10.1371/journal.pgph.0000298
Full text
 
Chen, F et al. The Role of Children in Household Transmission of COVID-19: A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases, Published:May 10, 2022
DOI:https://doi.org/10.1016/j.ijid.2022.05.016
Full text

Cheng, SMS. et al. SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022.  Eurosurveillance ,   Volume 27, Issue 18, 05/May/2022
Full text
 
Fisman, DN. et al. Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission. CMAJ April 25, 2022 194 (16) E573-E580; DOI: https://doi.org/10.1503/cmaj.212105
Full text
 
Gazit, S. et al. Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2022-071113 (Published 24 May 2022)
Full text

Hampshire, A . et al.  Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. eClinical Medicine Published:April 28, 2022DOI:https://doi.org/10.1016/j.eclinm.2022.101417
Full text

Huang, L. et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respiratory Medicine,  Published: May 11, 2022DOI:https://doi.org/10.1016/S2213-2600(22)00126-6
Full text

Jung J, Kim JY, Park H, et al. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals. JAMA Netw Open. 2022;5(5):e2213606. doi:10.1001/jamanetworkopen.2022.13606
Full text

Li, J et al. Recent SARS‐CoV‐2 infection: too early to vaccinate? Med J Aust 2022; 216 (9): 449-451. || doi: 10.5694/mja2.51499, Published online: 25 April 2022.
Full text

McCafferty, C., Cai, T., Borgel, D. et al. Pathophysiological pathway differences in children who present with COVID-19 ARDS compared to COVID -19 induced MIS-C. Nat Commun 13, 2391 (2022). https://doi.org/10.1038/s41467-022-29951-9
Full text
 
Nam SY, Jeon SW, Lee HS, Lim HJ, Lee DW, Yoo SS.
Demographic and Clinical Factors Associated With Anti–SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine Doses. JAMA Netw Open. 2022;5(5):e2212996. doi:10.1001/jamanetworkopen.2022.12996
Full text
 
Qiao, W., Lau, H.E., Xie, H. et al. SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nat Commun 13, 2539 (2022). https://doi.org/10.1038/s41467-022-30195-w
Full text
 
Seo, S., Han, JO., Shin, S. et al. Development of a social distancing monitoring system in Republic of Korea: results of a modified Delphi process. BMC Public Health 22, 860 (2022). https://doi.org/10.1186/s12889-022-13277-8
Full text
 
Sharma, A. et al.  Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant, Clinical Infectious Diseases, 2022;, ciac325, https://doi.org/10.1093/cid/ciac325
Full text
 
Tong, L et al.  A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2. Nature Metabolism, Published: 09 May 2022
Full text
 
Xue L, Jing S, Zhang K, Milne R, Wang H. Infectivity versus fatality of SARS-CoV-2 mutations and influenza [published online ahead of print, 2022 May 15]. Int J Infect Dis. 2022;S1201-9712(22)00295-8. doi:10.1016/j.ijid.2022.05.031
Full text
 
Yamasoba, D. et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell May 01, 2022DOI:https://doi.org/10.1016/j.cell.2022.04.035
Full text
 
Young R. Jang, et al.  Clinical Features and Duration of Viral Shedding Individuals with SARS-CoV-2 Omicron Variant Infection, Open Forum Infectious Diseases, 2022;, ofac237, https://doi.org/10.1093/ofid/ofac237
Full text

April 2022

Aknin, LB et al. Policy stringency and mental health during the COVID-19 pandemic: a longitudinal analysis of data from 15 countries. The Lancet Public Health, April 21, 2022, DOI:https://doi.org/10.1016/S2468-2667(22)00060-3
Full text
 
Bar-On YM. et al. Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. NEJM April 5, 2022, DOI: 10.1056/NEJMoa2201570
Full text
 
Block, JP et al. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination. MMWR Morb Mortal Wkly Rep 2022;71:517-523. DOI: http://dx.doi.org/10.15585/mmwr.mm7114e1
Full text
 
Chen C et al. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. The Journal of Infectious Diseases, 16 April 2022 DOI: https://doi.org/10.1093/infdis/jiac136
Full text

Chen G-L. et al.  Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Microbe
. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9
Full text
 
Chen, Z. et al. Global landscape of SARS-CoV-2 genomic surveillance and data sharing, Nature Genetics (2022). DOI: 10.1038/s41588-022-01033-y
Full text
 
Cui, D, et al. Rheumatic symptoms following COVID-19: a chronic post COVID-19 condition. Open Forum Infectious Diseases, 04 April 2022, DOI:  https://doi.org/10.1093/ofid/ofac170
Abstract
 
Han, JH et al. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza and Other Respiratory Viruses, 28 March 2022, DOI https://doi.org/10.1111/irv.12980
Full text

Katsoularis, I et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj-2021-069590 (Published 06 April 2022)
Full text
 
Ledford, H. Can drugs reduce the risk of long COVID? What scientists know so far. Nature, 25 March 2022, DOI d41586-022-00823-y
Full text
 
Ling RR et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. The Lancet Respiratory Medicine, April 11, 2022, DOI:https://doi.org/10.1016/S2213-2600(22)00059-5
Full text
 
Menni, C et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet, April 07, 2022, DOI:https://doi.org/10.1016/S0140-6736(22)00327-0
Full text
 
Moffitt, TE et al, Deep-seated psychological histories of COVID-19 vaccine hesitance and resistance, PNAS Nexus (2022). DOI: 10.1093/pnasnexus/pgac034
Full text
 
Morens DM et al. The Concept of Classical Herd Immunity May Not Apply to COVID-19. Journal of Infectious Diseases, 31 March 2022, DOI https://doi.org/10.1093/infdis/jiac109
Full text
 
Price, AM et al. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. NEJM March 30, 2022, DOI: 10.1056/NEJMoa2202826
Full text
 
Ridgway, JP et al. Rates of COVID-19 Among Unvaccinated Adults With Prior COVID-19. JAMA Netw Open. 2022;5(4):e227650. doi:10.1001/jamanetworkopen.2022.7650
Full text
 
Smith, DJ et al. COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022. MMWR Morb Mortal Wkly Rep 2022;71:545-548. DOI: http://dx.doi.org/10.15585/mmwr.mm7115e1external icon.
Full text

Wan, KH et al. Ocular surface disturbance in patients after acute COVID-19. Clin Exper Ophthalmology. 23 Feb 2022, DOI https://doi.org/10.1111/ceo.14066
Full text

Watson, C. Diabetes risk rises after COVID, massive study finds. Nature, 31 March 2022, DOI d41586-022-00912-y
Full text
 
Zachreson C et al. COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2. Science Advances, 8 Apr 2022 • Vol 8, Issue 14 • DOI: 10.1126/sciadv.abm3624
Full text

Influenza and COVID-19
Swets, MC. et al.  SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. The Lancet, 2022; DOI: 10.1016/S0140-6736(22)00383-X
Full text

March 2022

Alboksmaty, A et al. Effectiveness and safety of pulse oximetry in remote patient monitoring of patients with COVID-19: a systematic review. The Lancet: Digital Health  Volume 4, ISSUE 4, e279-e289, April 01, 2022. DOI: 10.1016/S2589-7500(21)00276-4
Full text

Allotey, J et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis. BMJ 2022; 376 doi: 10.1136/bmj-2021-067696 (Published 16 March 2022)
Full text

Arsenault, C., Gage, A., Kim, M.K. et al. COVID-19 and resilience of healthcare systems in ten countries. Nat Med (2022). DOI: 10.1038/s41591-022-01750-1
Full text

Arunachalam, PS et al. Durable protection against SARS-CoV-2 Omicron iBionduced by an adjuvanted subunit vaccine. BioRxiv 20 March 2022 DOI: 10.1101/2022.03.18.484950
Full text

Douaud, G  et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. Published online March 7, 2022. doi:10.1038/s41586-022-04569-5.
Full text

Gandhi, S., Klein, J., Robertson, A.J. et al. De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report. Nat Commun 13, 1547, 17 March 2022. DOI: 10.1038/s41467-022-29104-y
Full text

Luo, B et al.  Acidity of expiratory aerosols controls the infectivity of airborne influenza virus and SARS-CoV-2. medRxiv, 14 March 2022. DOI: 10.1101/2022.03.14.22272134
Full text

Messiah, SA et al.  Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents. Pediatrics,18 March (2022), DOI: 10.1542/peds.2021-055505
Full text

Rathmann, W et al. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia, 16 March 2022, DOI: 10.1007/s00125-022-05670-0
Full text

Regev-Yochay, G et al. 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC. medRxiv , 15 February 2022, doi: 10.1101/2022.02.15.22270948
Full text

Takahash K et al. Duration of infectious virus shedding by SARS-CoV-2 Omicron variant–infected vaccinees. Emerg Infect Dis. 2022 May. Original Publication Date: March 15, 2022, DOI: 10.3201/eid2805.220197
Full text

Tu, TM et al. Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore. JAMA Netw Open. 2022;5(3):e222940. DOI:10.1001/jamanetworkopen.2022.2940
Full text

Xie, Y and Al-Aly, Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet, 21 March 21 2022,  DOI: 10.1016/S2213-8587(22)00044-4
Full text

Yu, B et al.  Accelerating PERx Reaction Enables Covalent Nanobodies for Potent Neutralization of SARS-Cov-2 and Variants. bioRxiv 14 March 2022, doi: 10.1101/2022.03.11.483867
Full text

Yu, J et al. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants. March 16, 2022. DOI: 10.1056/NEJMc2201849
Full text

Wragg, KM et al, Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory. Nature Immunology, 21 March 2022. DOI: 10.1038/s41590-022-01175-5
Full text

Influenza and COVID-19

Su W, Wang H, Sun C, et al. The Association Between Previous Influenza Vaccination and Coronavirus Disease 2019 Infection Risk and Severity: A Systematic Review and Meta-Analysis [published online ahead of print, 2022 Mar 15]. Am J Prev Med. 2022, doi:10.1016/j.amepre.2022.02.008
Full text 

January 2022

Akther T, Nur T. A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use. PLoS One. 2022;17(1):e0261869. Published 2022 Jan 12. doi:10.1371/journal.pone.0261869
Full text
 
Alu A, Chen L, Lei H, Wei Y, Tian X, Wei X. Intranasal COVID-19 vaccines: From bench to bed [published online ahead of print, 2022 Jan 24]. EBioMedicine. 2022;76:103841. doi:10.1016/j.ebiom.2022.103841
Full text
 
Andeobu L, Wibowo S, Grandhi S. Medical Waste from COVID-19 Pandemic-A Systematic Review of Management and Environmental Impacts in Australia. Int J Environ Res Public Health. 2022;19(3):1381. Published 2022 Jan 26. doi:10.3390/ijerph19031381
Full text
 
Atmar RL, Lyke KE, Deming ME, et al. Homologous and Heterologous Covid-19 Booster Vaccinations [published online ahead of print, 2022 Jan 26]. N Engl J Med. 2022;NEJMoa2116414. doi:10.1056/NEJMoa2116414
Full text
 
Bae JH, Choe HJ, Holick MF, Lim S. Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review [published online ahead of print, 2022 Jan 4]. Rev Endocr Metab Disord. 2022;1-21. doi:10.1007/s11154-021-09705-6
Full text
 
Balakrishnan V, Ng KS, Kaur W, Lee ZL. COVID-19 mental health prevalence and its risk factors in South East Asia [published online ahead of print, 2022 Jan 12]. Curr Psychol. 2022;1-16. doi:10.1007/s12144-021-02556-z
Full text
 
Bravo, Lulu et al. “Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.” Lancet (London, England) vol. 399,10323 (2022): 461-472. doi:10.1016/S0140-6736(22)00055-1
Full text
 
Chatterjee B, Thakur SS. Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants. Expert Rev Vaccines. 2022;21(1):47-67. doi:10.1080/14760584.2022.1997601
Full text
 
Chen GL, Li XF, Dai XH, et al. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial [published online ahead of print, 2022 Jan 24]. Lancet Microbe. 2022;10.1016/S2666-5247(21)00280-9. doi:10.1016/S2666-5247(21)00280-9
Full text
 
Du Z, Wang L, Bai Y, et al. Cost-effective proactive testing strategies during COVID-19 mass vaccination: A modelling study. Lancet Reg Health Am. 2022;8:100182. doi:10.1016/j.lana.2021.100182
Full text
 
Enticott J, Gill JS, Bacon SL, et al. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia. BMJ Open. 2022;12(1):e057127. Published 2022 Jan 3. doi:10.1136/bmjopen-2021-057127
Full text
 
Gruell H, Vanshylla K, Tober-Lau P, et al. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant [published online ahead of print, 2022 Jan 19]. Nat Med. 2022;1-4. doi:10.1038/s41591-021-01676-0
Full text
 
Haas JW, Bender FL, Ballou S, et al. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis [published correction appears in JAMA Netw Open. 2022 Feb 1;5(2):e221277]. JAMA Netw Open. 2022;5(1):e2143955. Published 2022 Jan 4. doi:10.1001/jamanetworkopen.2021.43955
Full text
 
Huang Z, Fu Z, Wang J. Review on drug regulatory science promoting COVID-19 vaccine development in china [published online ahead of print, 2022 Jan 21]. Engineering (Beijing). 2022;10.1016/j.eng.2022.01.001. doi:10.1016/j.eng.2022.01.001
Full text
 
Hwang YC, Lu RM, Su SC, et al. Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. J Biomed Sci. 2022;29(1):1. Published 2022 Jan 4. doi:10.1186/s12929-021-00784-w
Full text
 
Israel A, Schäffer AA, Merzon E, et al. Predicting COVID-19 severity using major risk factors and received vaccines. Preprint. medRxiv. 2022;2021.12.31.21268575. Published 2022 Jan 3. doi:10.1101/2021.12.31.21268575
Full text
 
Jiang Y, Wu Q, Song P, You C. The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines. Front Med (Lausanne). 2022;8:806641. Published 2022 Jan 18. doi:10.3389/fmed.2021.806641
Full text
 
Jin Y, Hou C, Li Y, Zheng K, Wang C. mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2. Front Immunol. 2022;12:821538. Published 2022 Jan 21. doi:10.3389/fimmu.2021.821538
Full text
 
Joshi R, Singla R, Mishra A, et al. A systematic review on SARS-CoV-2 remission: an emerging challenge for its management, treatment, immunization strategies, and post-treatment guidelines. New Microbes New Infect. 2022;45:100949. doi:10.1016/j.nmni.2022.100949
Full text
 
Khandia R, Singhal S, Alqahtani T, et al. Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic [published online ahead of print, 2022 Jan 29]. Environ Res. 2022;209:112816. doi:10.1016/j.envres.2022.112816
Full text
 
Kim SH, Choi Y, Lee D, et al. Impact of COVID-19 on pregnant women in South Korea: Focusing on prevalence, severity, and clinical outcomes. J Infect Public Health. 2022;15(2):270-276. doi:10.1016/j.jiph.2022.01.004
Full text
 
Lally M. A cost-benefit analysis of COVID-19 lockdowns in Australia [published online ahead of print, 2022 Jan 28]. Monash Bioeth Rev. 2022;1-32. doi:10.1007/s40592-021-00148-y
Full text
 
Liao Q, Cowling BJ, Xiao J, et al. Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines. Vaccine. 2022;40(8):1074-1081. doi:10.1016/j.vaccine.2022.01.031
Full text
 
Liu H, Zhang J, Cai J, et al. Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China. BMC Med. 2022;20(1):37. Published 2022 Jan 31. doi:10.1186/s12916-022-02243-1
Full text
 
Malik JA, Ahmed S, Mir A, et al. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges. J Infect Public Health. 2022;15(2):228-240. doi:10.1016/j.jiph.2021.12.014
Full text
 
Masoudi M, Maasoumi R, Bragazzi NL. Effects of the COVID-19 pandemic on sexual functioning and activity: a systematic review and meta-analysis. BMC Public Health. 2022;22(1):189. Published 2022 Jan 28. doi:10.1186/s12889-021-12390-4
Full text
 
Mistry P, Barmania F, Mellet J, et al. SARS-CoV-2 Variants, Vaccines, and Host Immunity. Front Immunol. 2022;12:809244. Published 2022 Jan 3. doi:10.3389/fimmu.2021.809244
Full text
 
Norhayati MN, Che Yusof R, Azman YM. Systematic Review and Meta-Analysis of COVID-19 Vaccination Acceptance. Front Med (Lausanne). 2022;8:783982. Published 2022 Jan 27. doi:10.3389/fmed.2021.783982
Full text
 
Rahman S, Rahman MM, Miah M, et al. COVID-19 reinfections among naturally infected and vaccinated individuals. Sci Rep. 2022;12(1):1438. Published 2022 Jan 26. doi:10.1038/s41598-022-05325-5
Full text
 
Rasmussen SA, Jamieson DJ. COVID-19 and Pregnancy [published online ahead of print, 2022 Jan 31]. Infect Dis Clin North Am. 2022;doi:10.1016/j.idc.2022.01.002
Full text
 
Ren SY, Wang WB, Gao RD, Zhou AM. Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance. World J Clin Cases. 2022;10(1):1-11. doi:10.12998/wjcc.v10.i1.1
Full text
 
Sekizawa Y, Hashimoto S, Denda K, Ochi S, So M. Association between COVID-19 vaccine hesitancy and generalized trust, depression, generalized anxiety, and fear of COVID-19. BMC Public Health. 2022;22(1):126. Published 2022 Jan 18. doi:10.1186/s12889-021-12479-w
Full text
 
Shakeel CS, Mujeeb AA, Mirza MS, Chaudhry B, Khan SJ. Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors. Vaccines (Basel). 2022;10(1):110. Published 2022 Jan 12. doi:10.3390/vaccines10010110
Full text
 
Stein M, Ashkenazi-Hoffnung L, Greenberg D, et al. The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases. Vaccines (Basel). 2022;10(1):81. Published 2022 Jan 6. doi:10.3390/vaccines10010081
Full text
 
Tazerji SS, Shahabinejad F, Tokasi M, et al. Global data analysis and risk factors associated with morbidity and mortality of COVID-19. Gene Rep. 2022;26:101505. doi:10.1016/j.genrep.2022.101505
Full text
 
Tian X, Bai Z, Cao Y, et al. Evaluation of Clinical and Immune Responses in Recovered Children with Mild COVID-19. Viruses. 2022;14(1):85. Published 2022 Jan 4. doi:10.3390/v14010085
Full text
 
Tsheten T, Tenzin P, Clements ACA, Gray DJ, Ugyel L, Wangdi K. The COVID-19 vaccination campaign in Bhutan: strategy and enablers. Infect Dis Poverty. 2022;11(1):6. Published 2022 Jan 5. doi:10.1186/s40249-021-00929-x
Full text
 
Wang X, Shi L, Zhang Y, et al. A Comparative Retrospective Study of COVID-19 Responses in Four Representative Asian Countries. Risk Manag Healthc Policy. 2022;15:13-25. Published 2022 Jan 11. doi:10.2147/RMHP.S334326
Full text
 
Yang W, Greene SK, Peterson ER, et al. Epidemiological characteristics of the B.1.526 SARS-CoV-2 variant. Sci Adv. 2022;8(4):eabm0300. doi:10.1126/sciadv.abm0300
Full text
 
Zhang JJ, Dong X, Liu GH, Gao YD. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality [published online ahead of print, 2022 Jan 19]. Clin Rev Allergy Immunol. 2022;1-18. doi:10.1007/s12016-022-08921-5
Full text
 
Zhang M, Liang Y, Yu D, et al. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant. Int J Biol Sci. 2022;18(2):889-900. Published 2022 Jan 1. doi:10.7150/ijbs.68973
Full text
 
Influenza and COVID-19
Akaba H, Jindai K, Shobugawa Y, Oshitani H. Incidence and length of outbreak period of COVID-19 and population density in comparison with seasonal influenza in Japan. IJID Regions. 2022;2:154-157. doi:10.1016/j.ijregi.2022.01.003
Full text
 
Heithoff DM, Barnes L 5th, Mahan SP, et al. Assessment of a Smartphone-Based Loop-Mediated Isothermal Amplification Assay for Detection of SARS-CoV-2 and Influenza Viruses. JAMA Netw Open. 2022;5(1):e2145669. Published 2022 Jan 4. doi:10.1001/jamanetworkopen.2021.45669
Full text
 
Taniguchi Y, Kuno T, Komiyama J, et al. Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017-2020: a multicenter, retrospective cohort study in Japan. Lancet Reg Health West Pac. 2022;20:100365. doi:10.1016/j.lanwpc.2021.100365
Full text

 

(Updated 1 July 2022)